Whole Brain and Localized Magnetization Transfer Measurements Are Associated with Cognitive Impairment in Patients Infected with Human Immunodeficiency Virus

References

1. ↵
   McArthur JC, Brew BJ, Nath A. Neurological complications of HIV infection. Lancet Neurol 2005;4:543–55

   CrossRefPubMedWeb of Science
2. ↵
   Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001;410:988–94

   CrossRefPubMedWeb of Science
3. ↵
   Power C, Gill MJ, Johnson RT. Progress in clinical neurosciences: the neuropathogenesis of HIV infection–host-virus interaction and the impact of therapy. Can J Neurol Sci 2002;29:19–32

   PubMedWeb of Science
4. ↵
   Navia BA, Cho ES, Petito CK, et al. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986;19:525–35

   CrossRefPubMedWeb of Science
5. ↵
   Bell JE. An update on the neuropathology of HIV in the HAART era. Histopathology 2004;45:549–59

   CrossRefPubMed
6. ↵
   Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986;19:517–24

   CrossRefPubMedWeb of Science
7. ↵
   Post MJ, Berger JR, Quencer RM. Asymptomatic and neurologically symptomatic HIV-seropositive individuals: prospective evaluation with cranial MR imaging. Radiology 1991;178:131–39

   PubMedWeb of Science
8. ↵
   Koenig SH. Cholesterol of myelin is the determinant of gray-white contrast in MRI of brain. Magn Reson Med 1991;20:285–91

   PubMedWeb of Science
9. ↵
   Dousset V, Brochet B, Vital A, et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. AJNR Am J Neuroradiol 1995;16:225–31

   Abstract/FREE Full Text
10. ↵
    Wolff SD, Balaban RS. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 1989;10:135–44

    CrossRefPubMedWeb of Science
11. ↵
    Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483–91

    PubMedWeb of Science
12. Grossman RI, Gomori JM, Ramer KN, et al. Magnetization transfer: theory and clinical applications in neuroradiology. Radiographics 1994;14:279–90

    PubMedWeb of Science
13. ↵
    Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995;45:478–82

    Abstract/FREE Full Text
14. ↵
    van Buchem MA, Grossman RI, Armstrong C, et al. Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology 1998;50:1609–17

    Abstract/FREE Full Text
15. ↵
    Dousset V, Armand JP, Lacoste D, et al. Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy: Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. AJNR Am J Neuroradiol 1997;18:895–901

    Abstract/FREE Full Text
16. ↵
    van der Flier WM, van den Heuvel DM, Weverling-Rijnsburger AW, et al. Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann Neurol 2002;52:62–67

    CrossRefPubMedWeb of Science
17. ↵
    Ge Y, Kolson DL, Babb JS, et al. Whole brain imaging of HIV-infected patients: quantitative analysis of magnetization transfer ratio histogram and fractional brain volume. AJNR Am J Neuroradiol 2003;24:82–87

    Abstract/FREE Full Text
18. ↵
    Ragin AB, Storey P, Cohen BA, et al. Disease burden in HIV-associated cognitive impairment: a study of whole-brain imaging measures. Neurology 2004;63:2293–97

    Abstract/FREE Full Text
19. ↵
    McArthur JC, McDermott MP, McClernon D, et al. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol 2004;61:1687–96

    CrossRefPubMedWeb of Science
20. ↵
    Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis 1988;158:1079–83

    Abstract/FREE Full Text
21. ↵
    Marder K, Tang MX, Mejia H, et al. Risk of Parkinson's disease among first-degree relatives: a community-based study. Neurology 1996;47:155–60

    Abstract/FREE Full Text
22. ↵
    Marder K, Albert SM, McDermott MP, et al. Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment. Neurology 2003;60:1467–73

    Abstract/FREE Full Text
23. ↵
    Benjamini Y, Drai D, Elmer G, et al. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001;125:279–84

    CrossRefPubMedWeb of Science
24. ↵
    Grossman RI. Application of magnetization transfer imaging to multiple sclerosis. Neurology 1999;53:S8–11

    PubMedWeb of Science
25. ↵
    Hentschel F, Kreis M, Damian M, et al. Quantification of microangiopathic lesions in brain parenchyma and age-adjusted mean scores for the diagnostic separation of normal from pathological values in senile dementia [in German]. Rofo 2005;177:864–71

    PubMed
26. ↵
    van Buchem MA, McGowan JC, Grossman RI. Magnetization transfer histogram methodology: its clinical and neuropsychological correlates. Neurology 1999;53:S23–28

    CrossRefPubMedWeb of Science
27. ↵
    Rovaris M, Filippi M, Falautano M, et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998;50:1601–08

    Abstract/FREE Full Text
28. ↵
    Filley CM. White matter and behavioral neurology. Ann N Y Acad Sci 2005;1064:162–83

    CrossRefPubMedWeb of Science
29. ↵
    Filippi M, Rocca MA, Martino G, et al. Magnetization transfer changes in the normal-appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998;43:809–14

    CrossRefPubMedWeb of Science
30. ↵
    Loevner LA, Grossman RI, Cohen JA, et al. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;196:511–15

    PubMedWeb of Science
31. ↵
    Ernst T, Chang L, Witt M, et al. Progressive multifocal leukoencephalopathy and human immunodeficiency virus-associated white matter lesions in AIDS: magnetization transfer MR imaging. Radiology 1999;210:539–43

    PubMedWeb of Science
32. ↵
    Everall I, Barnes H, Spargo E, et al. Assessment of neuronal density in the putamen in human immunodeficiency virus (HIV) infection: application of stereology and spatial analysis of quadrats. J Neurovirol 1995;1:126–29

    CrossRefPubMedWeb of Science
33. ↵
    Filippi CG, Ulug AM, Ryan E, et al. Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. AJNR Am J Neuroradiol 2001;22:277–83

    Abstract/FREE Full Text
34. ↵
    Wu Y, Storey P, Cohen BA, et al. Diffusion alterations in corpus callosum of patients with HIV. AJNR Am J Neuroradiol 2006;27:656–60

    Abstract/FREE Full Text
35. ↵
    Pfefferbaum A, Rosenbloom MJ, Adalsteinsson E, et al. Diffusion tensor imaging with quantitative fibre tracking in HIV infection and alcoholism comorbidity: synergistic white matter damage. Brain 2007;130:48–64. Epub 2006 Sep 7

    Abstract/FREE Full Text
36. ↵
    Thompson PM, Dutton RA, Hayashi KM, et al. 3D mapping of ventricular and corpus callosum abnormalities in HIV/AIDS. Neuroimage 2006;2031:2012–23
37. ↵
    Budka H. HIV-associated neuropathology. In: Gendelman HE, Igor, Everall IP, et al, eds. The Neurology of AIDS. New York: Chapman & Hall;1998 :241–60
38. ↵
    Chang L, Lee PL, Yiannoutsos CT, et al. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. Neuroimage 2004;23:1336–47

    CrossRefPubMedWeb of Science
39. ↵
    von Giesen HJ, Wittsack HJ, Wenserski F, et al. Basal ganglia metabolite abnormalities in minor motor disorders associated with human immunodeficiency virus type 1. Arch Neurol 2001;58:1281–86

    CrossRefPubMed
40. ↵
    Ragin AB, Wu Y, Storey P, et al. Diffusion tensor imaging of subcortical brain injury in patients infected with human immunodeficiency virus. J Neurovirol 2005;11:292–98

    CrossRefPubMedWeb of Science
41. ↵
    Vavasour IM, Clark CM, Li DK, et al. Reproducibility and reliability of MR measurements in white matter: clinical implications. Neuroimage 2006;2032:2637–42
42. ↵
    Mesulam M. Brain, mind, and the evolution of connectivity. Brain Cogn 2000;42:4–6

    CrossRefPubMedWeb of Science
43. ↵
    Reuter-Lorenz, PA. Parallel processing in the bisected brain: implications for callosal function. In: Zaidel E, Iacoboni M, eds. The Parallel Brain: The Cognitive Neuroscience of the Corpus Callosum. Cambridge, Mass; MIT Press;2003
44. ↵
    Inglese M, van Waesberghe JH, Rovaris M, et al. The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS. Neurology 2003;60:853–60

    Abstract/FREE Full Text
45. ↵
    Filippi M, Dousset V, McFarland HF, et al. The role of MRI in the diagnosis and monitoring of multiple sclerosis: consensus report of the White Matter Study Group. J Magn Reson Imaging 2002;15:499–504

    CrossRefPubMedWeb of Science